ZEISS Medical Ecosystem - Digital Solutions Roll-out

Forecast refined for FY 2022/23 ZEISS Further growth at least in line with market expected despite geopolitical risks and difficult macroeconomic environment. Revenue expected to reach around €2.1b in FY 2022/23. Favorable long-term trends remain in place, such as aging population, growing volume of cataract surgeries, accelerating myopia prevalence and the need to improve both treatment efficiency as well as outcomes Ongoing high level of strategic investments in sales and marketing and research & development required to seize growth opportunities in our markets Sequentially stronger product mix expected in the second half of 2022/23, leading to recovery in EBIT margin from H1 levels Expected EBIT margin between 17% - 20% ZEISS Page 29

View entire presentation